ENTG Well Capitalized and Valued at 17% of Annual Revenue ENTG has superior performance to Canopy Groth but is trading at a miniscule 1% of Canopy's asking price,
ENTG also dramatically outperforms high profile Aurora Cannabis, though Aurora still trades in the $1.70 range.
ENTG is presently irrationallyvalued on paper at about 17% of reported revenues, and is strongly capitalized in comparison to most competitors for profitability into the future,
Finalized biomass ontracts with Hexo also dramitically reduce annual expense by10 million dollars and enable ENTG to fill a backlog of orders for their high demand quality products.
This is a penultimate opportunity at this price point for personal enrichment.
I invite all readers to compare ENTG fundamentals and achievements to most cannabis stocks to directly experience the brutality, manipulation, fear, anger and irrationality of the market. True value only appears when there is the purchase or sale of a company.
Entourage has far too many positive and innovative initiatives underway to discuss here, thus I strongly suggest revisiting all major achievements and developments particularly over the past couple of years @:
https://stockhouse.com/companies/quote?symbol=v.entg
...and don't forget to access 'View More News', as there is so much more there of substance as well.
Conratulationss in advance to any new investment partricipants, as they may attain percentages of profit beyond their wildest dreams,
Current holders are strongly advised to leverage their positions as well,